Alligator Bioscience
Privately held: no public share price · Sweden
Assets
(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
ALG.APV-527No recent activity | Phase 1/2 | 4-1BB (CD137) x 5T4Multispecific antibody | Solid Tumors |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.